| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-074
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06 |
| filingDate |
2004-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a2e1ac9d3abe7a5e010c73089431ea9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c95a24e7f0d13bc9926c4b9f35842e |
| publicationDate |
2005-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005025786-A1 |
| titleOfInvention |
Effects of sporoderm-broken germination activated ganoderma spores on promotion of proliferation and/or differentiation of neural stem cells in injured spinal cord |
| abstract |
The present invention provides a method for promoting proliferation and/or differentiation of neural stem cells in a mammal, which comprises orally administering sporoderm-broken germination activated Ganoderma lucidum spores (GASP) to the mammal. The effects of GASP on proliferation and/or differentiation of neural stem cells are particularly prominent in mammals after a spinal cord injury. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7281801-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006269568-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7344536-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004056018-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018135179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016310182-A1 |
| priorityDate |
2003-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |